A report of nonexistence of the non-Helicobacter pylori Helicobacter species in Iranian patients suffering from inflammatory bowel disease.


Journal

Folia microbiologica
ISSN: 1874-9356
Titre abrégé: Folia Microbiol (Praha)
Pays: United States
ID NLM: 0376757

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 13 10 2020
accepted: 31 05 2021
pubmed: 9 6 2021
medline: 17 11 2021
entrez: 8 6 2021
Statut: ppublish

Résumé

Inflammatory bowel disease is a chronic, relapsing-remitting gastrointestinal disorder which has become a serious global concern, and it imposes a great degree of health and economic burdens on communities worldwide. Although the presence of non-Helicobacter pylori Helicobacter (NHPH) microorganisms has been reported in various gastrointestinal disorders, their putative role in the pathogenesis of IBD has been a matter of controversy. The present study aimed to investigate the existence of gastric and enterohepatic NHPHs and their probable coinfection with H. pylori in IBD. Totally, 168 clinical specimens including 70 colonic biopsies and 98 fecal specimens were obtained from IBD patients. Genomic DNA was extracted from all samples, and its quality and concentration were assessed by β-globin PCR and spectrophotometry. The Helicobacter genus-specific PCR was performed using 16S rRNA gene. All samples were also tested for H. pylori infection by PCR of ureC gene fragment (glmM). The presence of NHPH was examined by using species-specific PCR assays. Based on PCR results, H. pylori was detected in 12.9% and 3.1% of colonic biopsies and fecal specimens, respectively. However, no statistically significant correlation was observed (P value > 0.05). We failed to find NHPH in both colonic biopsies and fecal specimens from IBD patients. Despite the fact that none of the IBD patients harbored the NHPH in the current work, further cohorts with larger sample size are required to determine the possible relationship between NHPH infection and IBD pathogenesis.

Identifiants

pubmed: 34101130
doi: 10.1007/s12223-021-00883-z
pii: 10.1007/s12223-021-00883-z
doi:

Substances chimiques

RNA, Ribosomal, 16S 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

751-759

Subventions

Organisme : Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
ID : RIGLD 995

Informations de copyright

© 2021. Institute of Microbiology, Academy of Sciences of the Czech Republic, v.v.i.

Références

Alatab S, Sepanlou SG, Ikuta K, Vahedi H, Bisignano C, Safiri S, Sadeghi A, Nixon MR, Abdoli A, Abolhassani H (2020) The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol 5:17–30
doi: 10.1016/S2468-1253(19)30333-4
Amorim I, Smet A, Alves O, Teixeira S, Saraiva AL, Taulescu M, Reis C, Haesebrouck F, Gärtner F (2015) Presence and significance of Helicobacter spp. in the gastric mucosa of Portuguese dogs. Gut Pathog 7:12
Arnold IC, Hitzler I, Müller A (2012) The immunomodulatory properties of Helicobacter pylori confer protection against allergic and chronic inflammatory disorders. Front Cell Infect Microbiol 2:10
pubmed: 22919602 pmcid: 3417532 doi: 10.3389/fcimb.2012.00010
Bell SJ, Chisholm SA, Owen RJ, Borriello SP, Kamm MA (2003) Evaluation of Helicobacter species in inflammatory bowel disease. Aliment Pharmacol Ther 18:481–486
pubmed: 12950420 doi: 10.1046/j.1365-2036.2003.01703.x pmcid: 12950420
Bohr URM, Glasbrenner B, Primus A, Zagoura A, Wex T, Malfertheiner P (2004) Identification of enterohepatic Helicobacter species in patients suffering from inflammatory bowel disease. J Clin Microbiol 42:2766–2768
pubmed: 15184464 pmcid: 427830 doi: 10.1128/JCM.42.6.2766-2768.2004
Bohr URM, Kuester D, Meyer F, Wex T, Stillert M, Csepregi A, Lippert H, Roessner A, Malfertheiner P (2007) Low prevalence of Helicobacteraceae in gall-stone disease and gall-bladder carcinoma in the German population. Clin Microbiol Infect 13:525–531
pubmed: 17346303 doi: 10.1111/j.1469-0691.2007.01690.x pmcid: 17346303
Burisch J, Jess T (2019) Does eradication of Helicobacter pylori cause inflammatory bowel disease? Clin Gastroenterol Hepatol 17:1940–1941
pubmed: 30768965 doi: 10.1016/j.cgh.2019.02.013 pmcid: 30768965
Cao DM, Lu QF, Li SB, Wang JP, Chen YL, Huang YQ, Bi HK (2016) Comparative genomics of H. pylori and non-pylori Helicobacter species to identify new regions associated with its pathogenicity and adaptability. BioMed Res Int 2016:6106029
Castaño-Rodríguez N, Kaakoush NO, Lee WS, Mitchell HM (2017) Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis. Gut 66(2):235–249
pubmed: 26508508 doi: 10.1136/gutjnl-2015-310545 pmcid: 26508508
De Groote D, Van Doorn LJ, Van den Bulck K, Vandamme P, Vieth M, Stolte M, Debongnie JC, Burette A, Haesebrouck F, Ducatelle R (2005) Detection of non-pylori Helicobacter species in “Helicobacter heilmannii”-infected humans. Helicobacter 10:398–406
pubmed: 16181350 doi: 10.1111/j.1523-5378.2005.00347.x pmcid: 16181350
Farzi N, Yadegar A, Sadeghi A, Asadzadeh Aghdaei H, Marian Smith S, Raymond J, Suzuki H, Zali MR (2019) High prevalence of antibiotic resistance in Iranian Helicobacter pylori Isolates: importance of functional and mutational analysis of resistance genes and virulence genotyping. J Clinical Med 8(11):2004
Foltz CJ, Fox GJ, Cahill R, Murphy JC, Yan L, Shames B, Schauer DB (1998) Spontaneous inflammatory bowel disease in multiple mutant mouse lines: association with colonization by Helicobacter hepaticus. Helicobacter 3:69–78
pubmed: 9631303 doi: 10.1046/j.1523-5378.1998.08006.x pmcid: 9631303
Fox JG, Shen Z, Xu S, Feng Y, Dangler CA, Dewhirst FE, Paster BJ, Cullen JM (2002) Helicobacter marmotae sp. nov. isolated from livers of woodchucks and intestines of cats. J Clin Microbiol 40:2513–2519
pubmed: 12089272 pmcid: 120550 doi: 10.1128/JCM.40.7.2513-2519.2002
Fox JG (2002) The non-H pylori helicobacters: their expanding role in gastrointestinal and systemic diseases. Gut 50:273–283
pubmed: 11788573 pmcid: 1773096 doi: 10.1136/gut.50.2.273
García A, Xu S, Dewhirst FE, Nambiar PR, Fox JG (2006) Enterohepatic Helicobacter species isolated from the ileum, liver and colon of a baboon with pancreatic islet amyloidosis. J Med Microbiol 55:1591–1595
pubmed: 17030922 doi: 10.1099/jmm.0.46707-0 pmcid: 17030922
Genta RM, Sonnenberg A (2015) Helicobacter-negative gastritis: a distinct entity unrelated to Helicobacter pylori infection. Aliment Pharmacol Ther 41:218–226
pubmed: 25376264 doi: 10.1111/apt.13007 pmcid: 25376264
Genta RM, Sonnenberg A (2012) Non-Helicobacter pylori gastritis is common among paediatric patients with inflammatory bowel disease. Aliment Pharmacol Ther 35:1310–1316
pubmed: 22486730 doi: 10.1111/j.1365-2036.2012.05090.x pmcid: 22486730
Germani Y, Dauga C, Duval P, Huerre M, Levy M, Pialoux G, Sansonetti P, Grimont PAD (1997) Strategy for the detection of Helicobacter species by amplification of 16S rRNA genes and identification of H. felis in a human gastric biopsy. Res Microbiol 148:315–326
pubmed: 9765810 doi: 10.1016/S0923-2508(97)81587-2 pmcid: 9765810
Goto K, Ohashi H, Takakura A, Itoh T (2000) Current status of Helicobacter contamination of laboratory mice, rats, gerbils, and house musk shrews in Japan. Curr Microbiol 41:161–166
pubmed: 10915200 doi: 10.1007/s002840010111 pmcid: 10915200
Greer CE, Wheeler CM, Manos MM (1994) Sample preparation and PCR amplification from paraffin-embedded. Genome Res 3:S113–S122
doi: 10.1101/gr.3.6.S113
Grehan M, Danon S, Lee A, Daskalopoulos G, Mitchell H (2004) Absence of mucosa-associated colonic Helicobacters in an Australian urban population. J Clin Microbiol 42:874–876
pubmed: 14766877 pmcid: 344510 doi: 10.1128/JCM.42.2.874-876.2004
Hansen R, Thomson JM, Fox JG, El-Omar EM, Hold GL (2011) Could Helicobacter organisms cause inflammatory bowel disease? FEMS Immunol Medical Microbiol 61:1–14
doi: 10.1111/j.1574-695X.2010.00744.x
Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VWS, Wu JCY, Chan FKL, Sung JJY, Kaplan GG, Ng SC (2017) Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterol 153:420–429
doi: 10.1053/j.gastro.2017.04.022
Kauser F, Hussain MA, Ahmed I, Ahmad N, Habeeb A, Khan AA, Ahmed N (2005) Comparing genomes of Helicobacter pylori strains from the high-altitude desert of Ladakh, India. J Clin Microbiol 43:1538–1545
pubmed: 15814963 pmcid: 1081395 doi: 10.1128/JCM.43.4.1538-1545.2005
Laharie DCA, Asselineau J, Bulois P, Bourreille A, Moreau J, Bonjean P, Lamarque D, Pariente A, Soulé JC (2009) Association between entero-hepatic Helicobacter species and Crohn’s disease: a prospective cross-sectional study. Aliment Pharmacol Ther 30:283–293
pubmed: 19438427 doi: 10.1111/j.1365-2036.2009.04034.x pmcid: 19438427
Li XX, Wong GL, To KF, Wong VW, Lai LH, Chow DK, Lau JY, Sung JJ, Ding C (2009) Bacterial microbiota profiling in gastritis without Helicobacter pylori infection or non-steroidal anti-inflammatory drug use. PloS One 4:e7985
Lo Presti A, Zorzi F, Del Chierico F, Altomare A, Cocca S, Avola A, De Biasio F, Russo A, Cella E, Reddel S (2019) Fecal and mucosal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease. Front Microbiol 10:1655
pubmed: 31379797 pmcid: 6650632 doi: 10.3389/fmicb.2019.01655
M’Koma AE (2014) Diagnosis of inflammatory bowel disease: potential role of molecular biometrics. World J Gastro Surg 6:208
doi: 10.4240/wjgs.v6.i11.208
Maggio-Price L, Bielefeldt-Ohmann H, Treuting P, Iritani M, B, Zeng W, Nicks A, Tsang M, Shows D, Morrissey P, Viney JL, (2005) Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a−/−mice results in colitis that progresses to dysplasia. Amer J Pathology 166:1793–1806
doi: 10.1016/S0002-9440(10)62489-3
Man SM, Zhang L, Day AS, Leach S, Mitchell H (2008) Detection of enterohepatic and gastric helicobacter species in fecal specimens of children with Crohn’s disease. Helicobacter 13:234–238
pubmed: 18665930 doi: 10.1111/j.1523-5378.2008.00607.x pmcid: 18665930
Murase K (2016) Gastritis with distinctive histopathology (non-Helicobacter pylori gastritis ). Acta Med Nagasaki 46:9–14
O’rourke JL, Grehan M, Lee A, (2001) Non-pylori Helicobacter species in humans. Gut 49:601–606
doi: 10.1136/gut.49.5.601
Øverby A, Murayama SY, Michimae H, Suzuki H, Suzuki M, Serizawa H, Tamura R, Nakamura S, Takahashi S, Nakamura M (2017) Prevalence of gastric non-Helicobacter pylori-Helicobacters in Japanese patients with gastric disease. Digestion 95:61–66
pubmed: 28052279 doi: 10.1159/000452400 pmcid: 28052279
Papamichael K, Konstantopoulos P, Mantzaris GJ (2014) Helicobacter pylori infection and inflammatory bowel disease: is there a link? World J Gastroenterol 20:6374
pubmed: 24914359 pmcid: 4047323 doi: 10.3748/wjg.v20.i21.6374
Peng X, Zhou L, Gong Y, Song Z, He L, Lin S, Zhang J (2017) Non-pylori Helicobacters (NHPHs) induce shifts in gastric microbiota in Helicobacter pylori-infected patients. Front Microbiol 8:1038
pubmed: 28642750 pmcid: 5462978 doi: 10.3389/fmicb.2017.01038
Peura DA, Haber MM, Hunt B, Atkinson S (2010) Helicobacter pylori-negative gastritis in erosive esophagitis, nonerosive reflux disease or functional dyspepsia patients. J Clin Gastroenterol 44:180–185
pubmed: 19687753 doi: 10.1097/MCG.0b013e3181ac9830 pmcid: 19687753
Powers-Fletcher MV, Couturier MR (2015) Non-Helicobacter pylori Helicobacter species associated with human disease: a primer for the clinical microbiology laboratory. Clin Microbiology Newsl 37:93–101
doi: 10.1016/j.clinmicnews.2015.05.004
Rimbara E, Mori S, Kim H, Matsui M, Suzuki S, Takahashi S, Yamamoto S, Mukai M, Shibayama K (2013) Helicobacter cinaedi and Helicobacter fennelliae transmission in a hospital from 2008 to 2012. J Clin Microbiol 51:2439–2442
pubmed: 23658263 pmcid: 3697726 doi: 10.1128/JCM.01035-13
Rocha M, Avenaud P, Menard A, Le Bail B, Balabaud C, Bioulac-Sage P, Magalhaes Queiroz DM, Megraud F (2005) Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma. Gut 54:396–401
pubmed: 15710989 pmcid: 1774397 doi: 10.1136/gut.2004.042168
Sayar R, Shokri Shirvani J, Hajian-Tilaki K, Vosough Z, Ranaei M (2019) The negative association between inflammatory bowel disease and Helicobacter pylori seropositivity. Caspian J Intern Med 10:217–222
pubmed: 31363401 pmcid: 6619465
Shiota S, Thrift AP, Green L, Shah R, Verstovsek G, Rugge M, Graham DY, El-Serag HB (2017) Clinical manifestations of Helicobacter pylori-negative gastritis. Clin Gastroenterol Hepatol 15:1037-1046.e3
pubmed: 28110098 doi: 10.1016/j.cgh.2017.01.006 pmcid: 28110098
Shomer NH, Dangler CA, Schrenzel MD, Fox JG (1997) Helicobacter bilis-induced inflammatory bowel disease in scid mice with defined flora. Infect Immun 65:4858–4864
pubmed: 9353076 pmcid: 175697 doi: 10.1128/iai.65.11.4858-4864.1997
Singh P, Ananthakrishnan A, Ahuja V (2017) Pivot to Asia: inflammatory bowel disease burden. Intest Res 15:138
pubmed: 28239326 pmcid: 5323305 doi: 10.5217/ir.2017.15.1.138
Thomson JM, Hansen R, Berry SH, Hope ME, Murray GI, Mukhopadhya I, McLean MH, Shen Z, Fox JG, El-Omar E (2011) Enterohepatic helicobacter in ulcerative colitis: potential pathogenic entities? PloS One 6(2):e17184
Vafaeimanesh J, Alebouyeh M, Seyyedmajidi M, Tajeddin E, Sherafat SJ (2012) Molecular Detection of Helicobacter species and other bacteria in human bile samples of patients with biliary diseases. J Gastrointest Dig Syst 2:1
doi: 10.4172/2161-069X.1000106
Van den Bulck K, Baele M, Hermans K, Ducatelle R, Haesebrouck R, Decostere A (2005) First report on the occurrence of ‘Helicobacter heilmannii’in the stomach of rabbits. Vet Res Commun 29:271–279
pubmed: 15751578 doi: 10.1023/B:VERC.0000048502.81661.64 pmcid: 15751578
Veijola L, Nilsson I, Halme L, Al-Soud WA, Mäkinen J, Ljungh A, Rautelin H (2007) Detection of Helicobacter species in chronic liver disease and chronic inflammatory bowel disease. Ann Med 39:554–560
pubmed: 17852032 doi: 10.1080/07853890701545714 pmcid: 17852032
Wu XW, Ji HZ, Yang MF, Wu L, Wang FU (2015) Helicobacter pylori infection and inflammatory bowel disease in Asians: a meta-analysis. World J Gastroenterol 21(15):4750–4756
pubmed: 25914487 pmcid: 4402325 doi: 10.3748/wjg.v21.i15.4750
Yadegar A, Alebouyeh M, Lawson AJ, Mirzaei T, Nazemalhosseini Mojarad E, Zali MR (2014a) Differentiation of non-pylori Helicobacter species based on PCR-restriction fragment length polymorphism of the 23S rRNA gene. World J Microbiol Biotechnol 30:1909–1917
pubmed: 24493015 doi: 10.1007/s11274-014-1615-2 pmcid: 24493015
Yadegar A, Mohabati Mobarez A, Alebouyeh M, Mirzaei T, Kwok T, Zali MR (2014b) Clinical relevance of cagL gene and virulence genotypes with disease outcomes in a Helicobacter pylori infected population from Iran. World J Microbiol Biotechnol 30:2481–2490
pubmed: 24854336 doi: 10.1007/s11274-014-1673-5 pmcid: 24854336
Yadegar A, Mohabati Mobarez A, Zali MR (2019) Genetic diversity and amino acid sequence polymorphism in Helicobacter pylori CagL hypervariable motif and its association with virulence markers and gastroduodenal diseases. Cancer Med 8:1619–1632
pubmed: 30873747 pmcid: 6488209 doi: 10.1002/cam4.1941
Yu Q, Zhang S, Li L, Xiong L, Chao K, Zhong B, Li Y, Wang H, Chen M (2015) Enterohepatic Helicobacter species as a potential causative factor in inflammatory bowel disease: a meta-analysis. Medicine 94(45):e1773
Yu Y, Zhu S, Li P, Min L, Zhang S (2018) Helicobacter pylori infection and inflammatory bowel disease: a crosstalk between upper and lower digestive tract. Cell Death Dis 9:1–12
doi: 10.1038/s41419-017-0012-9
Zhang L, Day A, McKenzie G, Mitchell H (2006) Nongastric Helicobacter species detected in the intestinal tract of children. J Clin Microbiol 44:2276–2279
pubmed: 16757639 pmcid: 1489454 doi: 10.1128/JCM.02017-05
Zuo T, Ng SC (2018) The gut microbiota in the pathogenesis and therapeutics of inflammatory bowel disease. Front Microbiol 9:2247
pubmed: 30319571 pmcid: 6167487 doi: 10.3389/fmicb.2018.02247

Auteurs

Samira Pirmanesh (S)

Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Nasrin Mirzaei (N)

Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Masoumeh Azimirad (M)

Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Abbas Yadegar (A)

Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran. a.yadegar@sbmu.ac.ir.

John Y Kao (JY)

Department of Internal Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, MI, USA.

Hamid Asadzadeh Aghdaei (HA)

Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Mohammad Reza Zali (MR)

Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH